Coexpression of interleukin-8 and inducible nitric oxide synthase in gastric mucosa infected with cagA+ Helicobacter pylori

Digestive Diseases and Sciences

Volumn 45, Issue 1, 2000, Pages 55-62

  Li, Chun Qi ^a,b   Pignatelli, Brigitte ^a   Ohshima, Hiroshi ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

CagA gene; Gastric mucosa; Helicobacter pylori; Inducible nitric oxide synthase; Interleukin 8

Indexed keywords

INTERLEUKIN 8; NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; ARTICLE; CHRONIC GASTRITIS; ENZYME INDUCTION; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH MUCOSA;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033994313     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005453125433     Document Type: Article

References (39)

1. 1. Mobley HL: Heticobacter pylori factors associated with disease development. Gastroenterology 113:S21-S28, 1997
2. 2. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez Perez GI, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136, 1991
3. 3. Parsonnet J, Harris RA, Hack HM, Owens DK: Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials. Lancet 348:150-154, 1996
4. 4. Tummuru MK, Cover TL, Blaser MJ: Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 61:1799-1809, 1993
5. 5. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332-335, 1991
6. 6. Blaser MJ, Perez PG, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111-2115, 1995
7. 7. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, Shiratori Y, Omata M: Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 42:338-343, 1998
8. 8. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464-1466, 1989
9. 9. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler U, Tahara E: Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 152:93-100, 1998
10. 10. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, Imanishi J: Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42:609-617, 1998
11. 11. Ando T, Kusugami K, Ohsuga M, Shinoda M, Sakakibara M, Saito H, Fukatsu A, Ichiyama S, Ohta M: Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am J Gastroenterol 91:1150-1156, 1996
12. 12. Crabtree JE, Farmery SM, Lindley IJ, Figura N, Peichl P, Tompkins DS: CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 47:945-950, 1994
13. 13. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R: Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 48:41-45, 1995
14. 14. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J: Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442-451, 1997
15. 15. Sharma SA, Tummuru MK, Miller GG, Blaser MJ: Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 63:1681-1687, 1995
16. 16. Tummuru MK, Sharma SA, Blaser MJ: Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 18:867-876, 1995
17. 17. Ohshima H, Bartsch H: Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res 305:253-264, 1994
18. 18. Pignatelli B, Bancel B, Estève J, Malaveille C, Calmels S, Correa P, Patricot LM, Laval M, Lyandrat N, Ohshima H: Inducible nitric oxide synthase, anti-oxidant enzymes and Helicobacter pylori infection in gastritis and gastric precancerous lesions in humans. Eur J Cancer Prev 7:439-447, 1998
19. 19. Pignatelli B, Bancel B, Malaveille C, Calmels S, Correa PM, Patricot LM, Laval M, Lyandrat N, Ohshima H: Helicobacter pylori infection oxidative stress and stomach cancer. In International Agency for Research on Cancer Biennial Report 1994/1995, Lyon, IARC, 1995, pp 101-102
20. 20. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ, Correa P: Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants. Cancer Res 56:3238-3243, 1996
21. 21. Bruch Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb Bachofen V: A proinflammatory activity of interleukin 8 in human skin: Expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 184:2007-2012, 1996
22. 22. Villarete LH, Remick DG: Nitric oxide regulation of interleukin-8 gene expression. Shock 7:29-35, 1997
23. 23. Andrew PJ, Harant H, Lindley IJ: Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem Biophys Res Commun 214:949-956, 1995
24. 24. McCall TB, Palmer RM, Moncada S: Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem Biophys Res Commun 186:680-685, 1992
25. 25. Peek RM Jr, Miller GG, Tham KT, Perez Perez GI, Cover TL, Atherton JC, Dunn GD, Blaser MJ: Detection of Helicobacter pylori gene expression in human gastric mucosa. J Clin Microbiol 33:28-32, 1995
26. 26. Gray SF, Wyatt JI, Rathbone BJ: Simplified techniques for identifying Campylobacter pyloridis. J Clin Pathol 39:1279, 1986
27. 27. Price AB: The Sydney System: Histological division. J Gastroenterol Hepatol 6:209-222, 1991
28. 28. Peek-RM J, Moss SF, Tham KT, Perez PG, Wang S. Miller GG, Atherton JC, Holt PR, Blaser MJ: Helicobacter pylori cagA + strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 89:863-868, 1997
29. 29. Peek-RM J, Miller GG, Tham KT, Perez PG, Zhao X, Atherton JC, Blaser MJ: Heightened inflammatory response and cytokine expression in vivo to cagA + Helicobacter pylori strains. Lab Invest 73:760-770, 1995
30. 30. Ambs S, Merriam WG, Bennett WP, Felley BE, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC: Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression. Cancer Res 58:334-341, 1998
31. 31. Weel JF, van der Hulst RW, Gerrits Y, Roorda P, Feller M, Dankert J, Tytgat GN, van der Ende A: The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 173:1171-1175, 1996
32. 32. Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J, van der Ende A: Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 35:1344-1347, 1997
33. 33. Miehlke S, Kibler K, Kim JG, Figura N, Small SM, Graham DY, Go MF: Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol 91:1322-1325, 1996
34. 34. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A: High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 32:465-468, 1997
35. 35. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648-14653, 1996
36. 36. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J: Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110:1744-1752, 1996
37. 37. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, Shiratori Y, Omata M: Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 44:336-341, 1999
38. 38. Rachmilewitz D, Karmeli F, Eliakim R, Stalnikowicz R, Ackerman Z, Amir G, Stamler JS: Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients. Gut 35:1394-1397. 1994
39. 39. Shapiro KB, Hotehkiss JH: Induction of nitric oxide synthesis in murine macrophages by Helicobacter pylori. Cancer Lett 102:49-56, 1996